Wealthfront Advisers
ELV icon

Wealthfront Advisers’s Elevance Health ELV Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$6.13M Buy
15,750
+2,042
+15% +$794K 0.02% 336
2025
Q1
$5.96M Buy
13,708
+7,400
+117% +$3.22M 0.02% 316
2024
Q4
$2.33M Sell
6,308
-7,006
-53% -$2.58M 0.01% 493
2024
Q3
$6.92M Sell
13,314
-941
-7% -$489K 0.02% 236
2024
Q2
$7.72M Buy
14,255
+254
+2% +$138K 0.03% 185
2024
Q1
$7.26M Sell
14,001
-400
-3% -$207K 0.03% 189
2023
Q4
$6.79M Buy
14,401
+3,345
+30% +$1.58M 0.03% 184
2023
Q3
$4.81M Sell
11,056
-1,224
-10% -$533K 0.02% 218
2023
Q2
$5.46M Sell
12,280
-4,144
-25% -$1.84M 0.02% 199
2023
Q1
$7.55M Sell
16,424
-6,490
-28% -$2.98M 0.03% 150
2022
Q4
$11.8M Buy
22,914
+1,740
+8% +$893K 0.06% 93
2022
Q3
$9.62M Sell
21,174
-736
-3% -$334K 0.05% 97
2022
Q2
$10.6M Buy
21,910
+2,642
+14% +$1.27M 0.05% 92
2022
Q1
$9.47M Buy
19,268
+5,340
+38% +$2.62M 0.04% 105
2021
Q4
$6.46M Buy
13,928
+46
+0.3% +$21.3K 0.03% 155
2021
Q3
$5.18M Buy
13,882
+6,476
+87% +$2.41M 0.02% 158
2021
Q2
$2.83M Buy
7,406
+1,153
+18% +$440K 0.01% 237
2021
Q1
$2.25M Buy
6,253
+1,004
+19% +$360K 0.01% 239
2020
Q4
$1.69M Buy
5,249
+435
+9% +$140K 0.01% 264
2020
Q3
$1.29M Buy
4,814
+39
+0.8% +$10.5K 0.01% 273
2020
Q2
$1.26M Sell
4,775
-523
-10% -$138K 0.01% 261
2020
Q1
$1.2M Sell
5,298
-1,195
-18% -$271K 0.01% 235
2019
Q4
$1.96M Buy
6,493
+614
+10% +$185K 0.01% 183
2019
Q3
$1.41M Sell
5,879
-1,196
-17% -$287K 0.01% 225
2019
Q2
$2M Sell
7,075
-23
-0.3% -$6.49K 0.02% 156
2019
Q1
$2.04M Buy
7,098
+1,314
+23% +$377K 0.02% 143
2018
Q4
$1.52M Buy
+5,784
New +$1.52M 0.02% 169